Fig. 5From: Exosomal TRIM3 is a novel marker and therapy target for gastric cancerTRIM3 overexpression inhibits gastric cancer growth and metastasis in vivo. a, The weight and volumes of tumors in control and TRIM3 overexpression groups. ((a). TRIM3-Vector; (b), TRIM3 overexpression). *P < 0.05, ** P < 0.01. b, The expression of TRIM3 and PCNA in subcutaneous tumor tissues was examined by using immunohistochemistry. Magnification, 200× (left panel); 400× (right panel). c, The number of metastatic tumor nodes in control and TRIM3 overexpression groups. **P < 0.01. d, The expression of TRIM3 and EMT associated proteins in the metastatic tumor nodes was detected by using immunohistochemistry. Magnification, 200× (left panel); 400× (right panel). e, The weight and volume of tumors in control and TRIM3-siRNA groups. *P < 0.01; **P < 0.05. f, The expression of TRIM3 and PCNA in subcutaneous tumor tissues was detected by using immunohistochemistry. Magnification, 200× (left panel); 400× (right panel). g, The number of metastatic tumor nodes in control and TRIM3-siRNA groups. *P < 0.05. h, The expression of TRIM3 and EMT associated proteins in the metastatic tumor nodes was detected by using immunohistochemistry. Magnification, 200× (left panel); 400× (right panel)Back to article page